https://stock.noler.com/us/stock/amicus-therapeutics-inc https://stock.noler.com/us/stock/amicus-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/amicus-therapeutics-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/amicus-therapeutics-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/amicus-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/accrued-royalties-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/amicus-therapeutics-inc/accumulated-oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/acquired-contingent-liability https://stock.noler.com/us/stock/amicus-therapeutics-inc/acquired-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/amicus-therapeutics-inc/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/amicus-therapeutics-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/amicus-therapeutics-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/amicus-therapeutics-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/acquisitions https://stock.noler.com/us/stock/amicus-therapeutics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/amicus-therapeutics-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/amicus-therapeutics-inc/activist-13d-13g-form-schedule-13g https://stock.noler.com/us/stock/amicus-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/amicus-therapeutics-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/amicus-therapeutics-inc/advertising-expense https://stock.noler.com/us/stock/amicus-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/amicus-therapeutics-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/amicus-therapeutics-inc/amended-reports-10-k https://stock.noler.com/us/stock/amicus-therapeutics-inc/amortization https://stock.noler.com/us/stock/amicus-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/amicus-therapeutics-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/amicus-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/amicus-therapeutics-inc/aoci https://stock.noler.com/us/stock/amicus-therapeutics-inc/area-of-real-estate-property https://stock.noler.com/us/stock/amicus-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/amicus-therapeutics-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-debt-unrealized-loss-position https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-securities https://stock.noler.com/us/stock/amicus-therapeutics-inc/available-for-sale-unrealized-loss-position-less-than-twelve-months-fair-value https://stock.noler.com/us/stock/amicus-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/amicus-therapeutics-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/amicus-therapeutics-inc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/amicus-therapeutics-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/amicus-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/amicus-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/amicus-therapeutics-inc/capital-lease-obligations https://stock.noler.com/us/stock/amicus-therapeutics-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/amicus-therapeutics-inc/capital-leases-lessee-balance-sheet-assets-by-major-class-accumulated-deprecation https://stock.noler.com/us/stock/amicus-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/amicus-therapeutics-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/amicus-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/amicus-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/amicus-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/amicus-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/amicus-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/amicus-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/amicus-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/amicus-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/amicus-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/amicus-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/amicus-therapeutics-inc/contract-liability https://stock.noler.com/us/stock/amicus-therapeutics-inc/contractual-obligation https://stock.noler.com/us/stock/amicus-therapeutics-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/amicus-therapeutics-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/amicus-therapeutics-inc/cost-of-goods-sold https://stock.noler.com/us/stock/amicus-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/amicus-therapeutics-inc/cost-of-revenue-2 https://stock.noler.com/us/stock/amicus-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/amicus-therapeutics-inc/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/amicus-therapeutics-inc/current-assets https://stock.noler.com/us/stock/amicus-therapeutics-inc/current-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/amicus-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/amicus-therapeutics-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/amicus-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/amicus-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-carrying-amount https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-fair-value https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-repaid https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-securities-realized-gain-loss https://stock.noler.com/us/stock/amicus-therapeutics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-compensation-liability-classified-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-compensation-liability-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-compensation-plan-assets https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-compensation-share-based-arrangements-liability-current-and-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-credits-and-other-liabilities-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-credits-and-other-liabilities-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-assets-gross-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-liabilities-gross-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/amicus-therapeutics-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/amicus-therapeutics-inc/defined-contribution-plan-maximum-annual-contribution-per-employee-percent https://stock.noler.com/us/stock/amicus-therapeutics-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/amicus-therapeutics-inc/depreciation https://stock.noler.com/us/stock/amicus-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/amicus-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/amicus-therapeutics-inc/derivative-asset-fair-value-gross-asset-gross https://stock.noler.com/us/stock/amicus-therapeutics-inc/derivative-fair-value-of-derivative-asset https://stock.noler.com/us/stock/amicus-therapeutics-inc/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/amicus-therapeutics-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/amicus-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/derivative-liability-fair-value-gross-liability-gross https://stock.noler.com/us/stock/amicus-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/amicus-therapeutics-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/amicus-therapeutics-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/amicus-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/amicus-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/eps https://stock.noler.com/us/stock/amicus-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/amicus-therapeutics-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/amicus-therapeutics-inc/extinguishment-of-debt-gain-loss-net-of-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/amicus-therapeutics-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/amicus-therapeutics-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/amicus-therapeutics-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/amicus-therapeutics-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/amicus-therapeutics-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/amicus-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/amicus-therapeutics-inc/fair-value-net-derivative-asset-liability-change-in-unrealized-gain-loss https://stock.noler.com/us/stock/amicus-therapeutics-inc/finance-lease-impairment-loss https://stock.noler.com/us/stock/amicus-therapeutics-inc/finance-lease-principal-payments https://stock.noler.com/us/stock/amicus-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/amicus-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/amicus-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/amicus-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/amicus-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/amicus-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/amicus-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/amicus-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/amicus-therapeutics-inc/foreign-currency-contracts-liability-fair-value-disclosure https://stock.noler.com/us/stock/amicus-therapeutics-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/foreign-pretax-income https://stock.noler.com/us/stock/amicus-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/amicus-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/amicus-therapeutics-inc/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/amicus-therapeutics-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/amicus-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/amicus-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/amicus-therapeutics-inc/goodwill https://stock.noler.com/us/stock/amicus-therapeutics-inc/goodwill-acquired https://stock.noler.com/us/stock/amicus-therapeutics-inc/goodwill-change https://stock.noler.com/us/stock/amicus-therapeutics-inc/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/amicus-therapeutics-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/amicus-therapeutics-inc/gross-profit https://stock.noler.com/us/stock/amicus-therapeutics-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/amicus-therapeutics-inc/impairment-of-leasehold https://stock.noler.com/us/stock/amicus-therapeutics-inc/income-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/amicus-therapeutics-inc/income-tax-paid-federal-after-refund-received https://stock.noler.com/us/stock/amicus-therapeutics-inc/income-tax-paid-state-and-local-after-refund-received https://stock.noler.com/us/stock/amicus-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/amicus-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/amicus-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/amicus-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/amicus-therapeutics-inc/increase-decrease-in-due-from-related-parties-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/amicus-therapeutics-inc/increase-decrease-in-operating-liabilities https://stock.noler.com/us/stock/amicus-therapeutics-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/amicus-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/amicus-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/amicus-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/amicus-therapeutics-inc/indefinitelived-intangible-assets-acquired https://stock.noler.com/us/stock/amicus-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/amicus-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/amicus-therapeutics-inc/insider-transactions-preferred/sales https://stock.noler.com/us/stock/amicus-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/amicus-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/amicus-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/amicus-therapeutics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/amicus-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/amicus-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/amicus-therapeutics-inc/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/amicus-therapeutics-inc/interest-expense-nonoperating https://stock.noler.com/us/stock/amicus-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/amicus-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/amicus-therapeutics-inc/interest-payable-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/inventory https://stock.noler.com/us/stock/amicus-therapeutics-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/amicus-therapeutics-inc/inventory-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/amicus-therapeutics-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/amicus-therapeutics-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/amicus-therapeutics-inc/inventory-write-down https://stock.noler.com/us/stock/amicus-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/amicus-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/amicus-therapeutics-inc/investment-income-interest-and-dividend https://stock.noler.com/us/stock/amicus-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/amicus-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/amicus-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/amicus-therapeutics-inc/level-3-asset-settlements https://stock.noler.com/us/stock/amicus-therapeutics-inc/level-3-liability-change https://stock.noler.com/us/stock/amicus-therapeutics-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/amicus-therapeutics-inc/level-3-liability-issues https://stock.noler.com/us/stock/amicus-therapeutics-inc/level-3-liability-settlements https://stock.noler.com/us/stock/amicus-therapeutics-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/amicus-therapeutics-inc/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/litigation-settlement-amount-awarded-to-other-party https://stock.noler.com/us/stock/amicus-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/marketable-securities-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/net-cash-from https://stock.noler.com/us/stock/amicus-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/amicus-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/amicus-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/amicus-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/amicus-therapeutics-inc/net-income https://stock.noler.com/us/stock/amicus-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/amicus-therapeutics-inc/new-claims-filed-number https://stock.noler.com/us/stock/amicus-therapeutics-inc/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/amicus-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/amicus-therapeutics-inc/number-of-reporting-units https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-available-for-sale-adjustment-before-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-available-for-sale-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-before-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-cash-flow-hedge-gain-loss-after-reclassification-and-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-before-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-foreign-currency-translation-adjustment-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-foreign-currency-translation-adjustment-tax-2 https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-foreign-currency-translation-gain-loss-arising-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-income https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-expense https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-future-minimum-sublease-rentals https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/amicus-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/amicus-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/other-amortization-of-deferred-charges https://stock.noler.com/us/stock/amicus-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/amicus-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/amicus-therapeutics-inc/other-noncash-income-expense https://stock.noler.com/us/stock/amicus-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/amicus-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/amicus-therapeutics-inc/other-nonoperating-income https://stock.noler.com/us/stock/amicus-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/amicus-therapeutics-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/amicus-therapeutics-inc/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/paid-in-capital-increase-in-carrying-amount-of-redeemable-preferred-stock https://stock.noler.com/us/stock/amicus-therapeutics-inc/paid-in-capital-share-based-compensation-restricted-stock-units-requisite-service-period-recognition https://stock.noler.com/us/stock/amicus-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/amicus-therapeutics-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/amicus-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/amicus-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/amicus-therapeutics-inc/patents-active https://stock.noler.com/us/stock/amicus-therapeutics-inc/patents-pending https://stock.noler.com/us/stock/amicus-therapeutics-inc/patents-rejected https://stock.noler.com/us/stock/amicus-therapeutics-inc/payment-for-contingent-consideration-liability-financing-activities https://stock.noler.com/us/stock/amicus-therapeutics-inc/payment-for-contingent-consideration-liability-operating-activities https://stock.noler.com/us/stock/amicus-therapeutics-inc/payments-for-capital-improvements https://stock.noler.com/us/stock/amicus-therapeutics-inc/payments-for-restructuring https://stock.noler.com/us/stock/amicus-therapeutics-inc/payments-for-tenant-improvements https://stock.noler.com/us/stock/amicus-therapeutics-inc/payments-of-financing-costs https://stock.noler.com/us/stock/amicus-therapeutics-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/amicus-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/amicus-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/amicus-therapeutics-inc/pretax-income-domestic https://stock.noler.com/us/stock/amicus-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-issuance-of-other-long-term-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-issuance-of-secured-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-unsecured-notes-payable https://stock.noler.com/us/stock/amicus-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/amicus-therapeutics-inc/product-warranty-accrual-noncurrent https://stock.noler.com/us/stock/amicus-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/amicus-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/amicus-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/amicus-therapeutics-inc/public-float https://stock.noler.com/us/stock/amicus-therapeutics-inc/purchase-obligation https://stock.noler.com/us/stock/amicus-therapeutics-inc/purchase-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/amicus-therapeutics-inc/purchase-obligation-due-in-second-year https://stock.noler.com/us/stock/amicus-therapeutics-inc/receivables-net-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/repayments-of-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/amicus-therapeutics-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/amicus-therapeutics-inc/repayments-of-secured-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/amicus-therapeutics-inc/research-and-development-in-process https://stock.noler.com/us/stock/amicus-therapeutics-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/amicus-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/amicus-therapeutics-inc/restructuring-charges https://stock.noler.com/us/stock/amicus-therapeutics-inc/restructuring-reserve https://stock.noler.com/us/stock/amicus-therapeutics-inc/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/amicus-therapeutics-inc/restructuring-reserve-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/restructuring-reserve-settled-without-cash https://stock.noler.com/us/stock/amicus-therapeutics-inc/restructuring-reserve-translation-and-other-adjustment https://stock.noler.com/us/stock/amicus-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/amicus-therapeutics-inc/revenue https://stock.noler.com/us/stock/amicus-therapeutics-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/amicus-therapeutics-inc/revenues https://stock.noler.com/us/stock/amicus-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/amicus-therapeutics-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/amicus-therapeutics-inc/sales-revenue-net https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-10-k https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-10-q https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-15-12g https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-25-nse https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-8-k https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-ars https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-certnas https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-ct-order https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-def-14a https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-defa14a https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-defm14a https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-prem14a https://stock.noler.com/us/stock/amicus-therapeutics-inc/sec-filings-regdex https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-posasr https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/amicus-therapeutics-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/amicus-therapeutics-inc/secured-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/secured-debt-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/secured-long-term-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/amicus-therapeutics-inc/share-based-goods-and-nonemployee-services-transaction-expense https://stock.noler.com/us/stock/amicus-therapeutics-inc/share-based-goods-and-nonemployee-services-transaction-stockholders-equity https://stock.noler.com/us/stock/amicus-therapeutics-inc/share-price https://stock.noler.com/us/stock/amicus-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/amicus-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/amicus-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/amicus-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/amicus-therapeutics-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-award-award-vesting-rights-percentage https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/amicus-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-gilti-amount https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-gilti-percent https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-reconciliation-tax-contingencies https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/amicus-therapeutics-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/amicus-therapeutics-inc/taxes-payable-current https://stock.noler.com/us/stock/amicus-therapeutics-inc/temporary-equity-accretion-of-dividends https://stock.noler.com/us/stock/amicus-therapeutics-inc/total-assets https://stock.noler.com/us/stock/amicus-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/amicus-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/amicus-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/trading-securities https://stock.noler.com/us/stock/amicus-therapeutics-inc/trading-securities-unrealized-holding-gain-loss https://stock.noler.com/us/stock/amicus-therapeutics-inc/treasury-shares-acquired https://stock.noler.com/us/stock/amicus-therapeutics-inc/treasury-stock-common-shares https://stock.noler.com/us/stock/amicus-therapeutics-inc/treasury-stock-common-value https://stock.noler.com/us/stock/amicus-therapeutics-inc/unrealized-gain-loss-on-securities https://stock.noler.com/us/stock/amicus-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/amicus-therapeutics-inc/unsecured-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/unsecured-long-term-debt https://stock.noler.com/us/stock/amicus-therapeutics-inc/utb-decrease-from-settlements https://stock.noler.com/us/stock/amicus-therapeutics-inc/utb-income-tax-penalties-accrued https://stock.noler.com/us/stock/amicus-therapeutics-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/amicus-therapeutics-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/amicus-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/amicus-therapeutics-inc/utb-interest-on-income-taxes-accrued https://stock.noler.com/us/stock/amicus-therapeutics-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/amicus-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/amicus-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/amicus-therapeutics-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/amicus-therapeutics-inc/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/amicus-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted